Recruiting

Observational Study

Sponsor:

Unity Health Toronto

Code:

NCT06353737

Conditions

Mpox (Monkeypox)

Eligibility Criteria

Sex: Male

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Mpox is caused by a virus that can be spread through touching the affected skin of someone who has the infection, touching sheets or clothes that has been used by someone with the infection, or breathing in particles of virus from someone who has the infection. Mpox infection can cause skin and flu-like symptoms, but can also cause very few symptoms, or no symptoms at all. While the number of participants with mpox symptoms can be tracked, little is known about how many people have mpox, but experience few or no symptoms at all. To do this, a Canadian sample of gay, bisexual and other men who have sex with men (GBMSM) who are participating in a randomized controlled trial will be screened for mpox symptoms. Screening will include questions about whether they may be experiencing any mpox symptoms, history of past diagnosis of mpox, sexual history, and vaccination history and awareness. Swabs will be taken to test for the presence of mpox virus, and a blood sample will be taken to test for antibodies. Approximately 450 individuals will be recruited. The results will be descriptive in nature.

Conditions

Mpox (Monkeypox)

Study ID

NCT06353737

Start date

Apr 1, 2024

Status verified date

Apr, 2024

Completion date

Mar 31, 2026

Anticipated

Primary completion date

Mar 31, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Male

Age: 0+

Healthy Volunteers: Not accepted

Inclusion criteria:

- Participants need to have been enrolled in an existing randomized clinical trial (NCT04762134)

Exclusion criteria:

- None

Study Design

Enrollment

450 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Asymptomatic prevalence [ Time Frame: 2 weeks ]

Central Contacts and Locations

Central contacts

Locations

Unity Health Toronto

Recruiting

Toronto, Ontario, Canada, M5B 1T8

Contacts

Principal Investigator:

Darrell HS Tan

More Information

Sponsor

Unity Health Toronto

Last update posted

Apr 18, 2024

Last verified

Apr, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Unity Health Toronto on 2024-04-18.